Concord Biotech, 543960, CONCORDBIO Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,339.61
72.82
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,283.47
0.41%
12.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.34
-
11.41

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.08
-
1.23

PAT CAGR (%)

10 Years
5 Years
3 Years

15.91
-
0.67

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 240.80 240.68 0.05% 262.35 158.90 65.10% 194.83 181.00 7.64% 0.00 0.00 0
Expenses 134.87 129.00 4.55% 143.16 120.98 18.33% 122.67 116.37 5.41% 0.00 0.00 0
EBITDA 105.93 111.68 -5.15% 119.19 37.92 214.32% 72.15 64.63 11.64% 0.00 0.00 0
EBIDTM 43.99% 46.40% 45.43% 23.86% 37.03% 35.71% 0.00% 0.00%
Other Income 8.19 9.25 -11.46% 8.13 6.03 34.83% 6.65 7.83 -15.07% 0.00 0.00 0
Interest 0.50 0.91 -45.05% 0.84 1.11 -24.32% 0.75 1.04 -27.88% 0.00 0.00 0
Depreciation 13.54 13.77 -1.67% 13.29 12.51 6.24% 13.04 13.57 -3.91% 0.00 0.00 0
PBT 100.09 106.25 -5.80% 113.18 30.33 273.16% 65.01 57.86 12.36% 0.00 0.00 0
Tax 25.53 27.17 -6.04% 28.69 7.88 264.09% 16.54 14.76 12.06% 0.00 0.00 0
PAT 74.55 79.08 -5.73% 84.49 22.45 276.35% 48.47 43.10 12.46% 0.00 0.00 0
PATM 30.96% 32.85% 32.21% 14.13% 24.88% 23.81% 0.00% 0.00%
EPS 7.13 7.56 -5.69% 8.08 2.15 275.81% 4.63 4.12 12.38% 0.00 0.00 0

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 240.80 240.68 0.05% 262.35 158.90 65.10% 194.83 181.00 7.64% 0.00 0.00 0
Expenses 134.87 129.00 4.55% 143.16 120.98 18.33% 122.67 116.37 5.41% 0.00 0.00 0
EBITDA 105.93 111.68 -5.15% 119.19 37.92 214.32% 72.15 64.63 11.64% 0.00 0.00 0
EBIDTM 43.99% 46.40% 45.43% 23.86% 37.03% 35.71% 0.00% 0.00%
Other Income 8.19 9.25 -11.46% 8.13 6.03 34.83% 6.65 7.83 -15.07% 0.00 0.00 0
Interest 0.50 0.91 -45.05% 0.84 1.11 -24.32% 0.75 1.04 -27.88% 0.00 0.00 0
Depreciation 13.54 13.77 -1.67% 13.29 12.51 6.24% 13.04 13.57 -3.91% 0.00 0.00 0
PBT 100.09 106.25 -5.80% 113.18 30.33 273.16% 65.01 57.86 12.36% 0.00 0.00 0
Tax 25.53 27.17 -6.04% 28.69 7.88 264.09% 16.54 14.76 12.06% 0.00 0.00 0
PAT 74.55 79.08 -5.73% 84.49 22.45 276.35% 48.47 43.10 12.46% 0.00 0.00 0
PATM 30.96% 32.85% 32.21% 14.13% 24.88% 23.81% 0.00% 0.00%
EPS 7.41 7.40 0.14% 7.74 2.10 268.57% 5.21 0.43 1,111.63% 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 23 Mar 22 Mar 21 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales - 853.17 712.93 616.94 276.17 238.53 204.82 164.91 135.60 108.59 104.70 Net Sales Growth - 19.67% 15.56% 123.39% 15.78% 16.46% 24.20% 21.62% 24.87% 3.72% Cost Of Goods Sold - 180.21 164.01 111.56 63.26 54.22 48.88 34.30 25.07 16.78 20.58 Gross Profit - 672.96 548.92 505.37 212.91 184.31 155.93 130.61 110.53 91.81 84.12 GP Margin - 78.88% 76.99% 81.92% 77.09% 77.27% 76.13% 79.20% 81.51% 84.55% 80.34% Total Expenditure - 504.59 439.01 289.01 140.63 127.67 119.26 88.75 69.85 49.51 44.97 Power & Fuel Cost - 97.65 71.64 39.86 26.89 28.90 29.45 25.71 21.27 15.15 11.70 % Of Sales - 11.45% 10.05% 6.46% 9.74% 12.12% 14.38% 15.59% 15.69% 13.95% 11.17% Employee Cost - 110.28 95.69 69.47 22.87 19.78 15.57 13.44 10.88 8.27 4.62 % Of Sales - 12.93% 13.42% 11.26% 8.28% 8.29% 7.60% 8.15% 8.02% 7.62% 4.41% Manufacturing Exp. - 38.44 32.45 21.97 12.42 12.32 12.35 8.45 7.00 4.99 3.36 % Of Sales - 4.51% 4.55% 3.56% 4.50% 5.16% 6.03% 5.12% 5.16% 4.60% 3.21% General & Admin Exp. - 37.41 31.09 22.52 8.72 6.53 6.42 3.54 2.59 1.81 1.60 % Of Sales - 4.38% 4.36% 3.65% 3.16% 2.74% 3.13% 2.15% 1.91% 1.67% 1.53% Selling & Distn. Exp. - 23.70 21.44 13.36 4.80 4.40 3.68 2.00 1.44 1.73 1.23 % Of Sales - 2.78% 3.01% 2.17% 1.74% 1.84% 1.80% 1.21% 1.06% 1.59% 1.17% Miscellaneous Exp. - 16.89 22.69 10.26 1.67 1.52 2.90 1.31 1.59 0.77 1.23 % Of Sales - 1.98% 3.18% 1.66% 0.60% 0.64% 1.42% 0.79% 1.17% 0.71% 1.79% EBITDA - 348.58 273.92 327.93 135.54 110.86 85.56 76.16 65.75 59.08 59.73 EBITDA Margin - 40.86% 38.42% 53.15% 49.08% 46.48% 41.77% 46.18% 48.49% 54.41% 57.05% Other Income - 35.31 23.42 13.81 4.58 5.51 2.83 5.31 2.58 3.81 1.77 Interest - 9.80 6.13 1.05 0.32 0.82 0.70 0.30 0.41 0.35 0.47 Depreciation - 54.03 50.05 27.52 10.46 9.67 11.43 10.14 8.97 7.26 5.10 PBT - 320.05 241.16 313.17 129.34 105.88 76.25 71.04 58.95 55.28 55.92 Tax - 81.93 62.59 77.83 42.09 35.63 21.83 21.65 17.17 16.00 19.20 Tax Rate - 25.60% 25.95% 24.85% 32.54% 33.65% 28.63% 30.48% 29.13% 28.94% 34.33% PAT - 238.13 178.57 235.33 87.25 70.25 54.41 49.39 41.78 39.28 36.72 PAT before Minority Interest - 238.13 178.57 235.33 87.25 70.25 54.41 49.39 41.78 39.28 36.72 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 27.91% 25.05% 38.14% 31.59% 29.45% 26.56% 29.95% 30.81% 36.17% 35.07% PAT Growth - 33.35% -24.12% 169.72% 24.20% 29.11% 10.16% 18.21% 6.36% 6.97% EPS - 22.77 17.07 22.50 8.34 6.72 5.20 4.72 3.99 3.76 3.51

Description TTM Mar 23 Mar 22 Mar 21
Net Sales - 853.17 712.93 616.94 Net Sales Growth - 19.67% 15.56% Cost Of Goods Sold - 180.21 164.01 111.56 Gross Profit - 672.96 548.92 505.38 GP Margin - 78.88% 76.99% 81.92% Total Expenditure - 504.59 439.01 289.01 Power & Fuel Cost - 97.65 71.64 39.86 % Of Sales - 11.45% 10.05% 6.46% Employee Cost - 110.28 95.69 69.47 % Of Sales - 12.93% 13.42% 11.26% Manufacturing Exp. - 38.45 32.48 21.97 % Of Sales - 4.51% 4.56% 3.56% General & Admin Exp. - 37.41 31.09 22.52 % Of Sales - 4.38% 4.36% 3.65% Selling & Distn. Exp. - 23.70 21.44 13.36 % Of Sales - 2.78% 3.01% 2.17% Miscellaneous Exp. - 16.89 22.66 10.26 % Of Sales - 1.98% 3.18% 1.66% EBITDA - 348.58 273.92 327.93 EBITDA Margin - 40.86% 38.42% 53.15% Other Income - 35.31 23.42 13.81 Interest - 9.80 6.13 1.05 Depreciation - 54.03 50.05 27.52 PBT - 320.05 241.16 313.17 Tax - 81.93 62.59 77.83 Tax Rate - 25.60% 25.95% 24.85% PAT - 240.08 174.93 235.34 PAT before Minority Interest - 240.08 174.93 235.34 Minority Interest - 0.00 0.00 0.00 PAT Margin - 28.14% 24.54% 38.15% PAT Growth - 37.24% -25.67% EPS - 22.95 16.72 22.50

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Shareholder's Funds 1,291.98 1,107.16 999.67 226.47 185.52 146.30 111.20 77.28 64.87 53.97 Share Capital 10.46 9.51 9.51 9.21 4.60 4.60 4.60 2.30 2.53 2.41 Total Reserves 1,281.52 1,097.65 990.16 217.26 180.92 141.69 106.60 74.98 62.34 51.56 Non-Current Liabilities 225.69 54.40 77.43 10.53 9.03 7.94 7.97 5.90 10.01 10.76 Secured Loans 6.24 31.25 56.25 0.00 0.00 0.00 0.00 2.27 7.23 7.62 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 195.85 1.87 2.10 0.27 0.28 0.55 0.78 0.00 0.00 0.00 Current Liabilities 181.53 340.97 235.93 37.96 27.55 24.26 21.01 16.30 16.27 9.22 Trade Payables 93.80 83.11 46.40 15.38 9.03 6.95 5.22 8.35 4.10 2.12 Other Current Liabilities 60.26 62.70 53.58 3.93 2.28 3.58 6.45 1.54 1.22 0.64 Short Term Borrowings 0.00 4.34 5.10 4.97 3.62 6.59 3.86 0.00 0.00 0.00 Short Term Provisions 27.48 190.82 130.85 13.68 12.62 7.15 5.47 6.41 10.95 6.46 Total Liabilities 1,699.20 1,502.53 1,313.03 274.96 222.10 178.50 140.18 99.48 91.15 73.95 Net Block 592.98 572.98 546.22 98.73 81.62 69.48 63.94 40.42 32.99 35.62 Gross Block 791.69 718.85 644.29 161.05 132.77 110.61 96.21 65.56 52.98 51.09 Accumulated Depreciation 198.71 145.87 98.08 62.31 51.15 41.14 32.28 25.14 19.99 15.47 Non Current Assets 971.50 869.87 705.89 113.02 88.35 87.86 73.36 52.46 39.43 35.74 Capital Work in Progress 172.70 74.16 17.95 8.02 3.97 14.42 7.00 12.04 6.44 0.12 Non Current Investment 0.79 0.92 0.67 0.56 0.56 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 196.84 220.99 140.61 5.72 2.00 3.77 2.41 0.00 0.00 0.00 Other Non Current Assets 8.19 0.82 0.45 0.00 0.21 0.19 0.00 0.00 0.00 0.00 Current Assets 727.70 632.67 607.15 161.94 133.75 90.64 66.81 47.03 51.72 38.22 Current Investments 136.93 73.47 140.99 0.00 2.00 2.02 0.00 3.01 12.03 0.00 Inventories 212.31 195.12 153.61 39.41 34.36 23.66 18.75 14.04 14.99 19.38 Sundry Debtors 273.76 232.17 177.52 100.35 85.43 54.83 30.17 23.82 10.91 9.36 Cash & Bank 43.45 88.93 60.82 2.67 1.53 1.04 12.22 0.61 0.23 1.18 Other Current Assets 61.25 32.53 40.37 8.92 10.42 9.09 5.67 5.54 13.55 8.29 Short Term Loans & Adv. 15.68 10.44 33.85 10.58 2.76 2.83 2.07 5.34 13.41 8.14 Net Current Assets 546.17 291.70 371.22 123.98 106.20 66.38 45.81 30.73 35.45 28.99 Total Assets 1,699.20 1,502.54 1,313.04 274.96 222.10 178.50 140.17 99.49 91.15 73.96

Description Mar 23 Mar 22 Mar 21
Shareholder's Funds 1,290.00 1,103.22 999.37 Share Capital 10.46 9.51 9.51 Total Reserves 1,279.54 1,093.71 989.86 Non-Current Liabilities 32.14 54.40 77.43 Secured Loans 6.24 31.25 56.25 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 2.30 1.87 2.10 Current Liabilities 376.40 344.24 235.93 Trade Payables 93.80 83.11 46.40 Other Current Liabilities 61.57 65.98 53.58 Short Term Borrowings 0.00 4.34 5.10 Short Term Provisions 221.03 190.82 130.85 Total Liabilities 1,698.54 1,501.86 1,312.73 Net Block 592.98 572.98 546.22 Gross Block 792.79 718.85 645.33 Accumulated Depreciation 199.81 145.87 99.11 Non Current Assets 970.84 869.20 705.59 Capital Work in Progress 172.70 74.16 17.95 Non Current Investment 0.13 0.26 0.37 Long Term Loans & Adv. 196.84 220.99 140.61 Other Non Current Assets 8.19 0.82 0.45 Current Assets 727.70 632.67 607.15 Current Investments 136.93 73.47 140.99 Inventories 212.31 195.12 153.61 Sundry Debtors 273.76 232.17 177.52 Cash & Bank 43.45 88.93 60.82 Other Current Assets 61.26 32.53 40.37 Short Term Loans & Adv. 15.68 10.44 33.85 Net Current Assets 351.30 288.42 371.22 Total Assets 1,698.54 1,501.87 1,312.74

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Cash From Operating Activity 246.00 207.47 166.81 39.81 21.53 16.14 36.04 34.70 18.96 -0.37 PBT 320.05 241.16 313.17 76.25 71.04 58.95 55.28 55.92 14.21 5.22 Adjustment 48.51 49.16 17.59 15.07 8.58 8.18 7.52 5.26 5.08 5.57 Changes in Working Capital -52.29 -22.06 -88.77 -24.01 -41.68 -33.34 -11.66 -9.66 3.93 -9.44 Cash after chg. in Working capital 316.28 268.26 241.99 67.30 37.94 33.79 51.14 51.53 23.22 1.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -70.28 -60.78 -75.18 -27.49 -16.41 -17.64 -15.10 -16.82 -4.39 -1.72 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.00 Cash From Investing Activity -157.95 -111.79 -195.20 -31.41 -10.85 -21.79 -22.40 -8.71 -20.05 -1.58 Net Fixed Assets -171.38 -130.77 -493.17 -32.33 -11.71 -21.82 -25.61 -18.18 -8.21 Net Investments -63.33 67.27 -141.10 2.00 -0.54 -2.02 3.01 9.02 -12.03 Others 76.76 -48.29 439.07 -1.08 1.40 2.05 0.20 0.45 0.19 Cash from Financing Activity -85.22 -100.16 31.12 -9.32 -9.82 -3.83 -1.98 -25.61 0.14 1.56 Net Cash Inflow / Outflow 2.83 -4.48 2.74 -0.91 0.85 -9.48 11.66 0.38 -0.95 -0.39 Opening Cash & Equivalents 0.67 5.14 2.41 3.52 2.66 12.14 0.57 0.23 1.18 1.58 Closing Cash & Equivalent 3.50 0.67 5.14 2.60 3.52 2.66 12.22 0.61 0.23 1.18

Description Mar 23 Mar 22 Mar 21
Cash From Operating Activity 246.00 207.47 166.82 PBT 322.01 237.52 312.72 Adjustment 46.55 52.80 18.04 Changes in Working Capital -52.28 -22.05 -88.76 Cash after chg. in Working capital 316.28 268.26 241.99 Interest Paid 0.00 0.00 0.00 Tax Paid -70.28 -60.78 -75.18 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -157.95 -111.79 -195.21 Net Fixed Assets -171.38 -130.77 Net Investments -63.33 67.27 Others 76.76 -48.29 Cash from Financing Activity -85.22 -100.16 31.12 Net Cash Inflow / Outflow 2.83 -4.48 2.74 Opening Cash & Equivalents 0.67 5.14 2.41 Closing Cash & Equivalent 3.50 0.67 5.14

Financial Ratios

Standalone /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08
Book Value (Rs.) 123.50 105.83 95.56 246.02 403.07 317.85 241.60 335.83 256.06 223.69 ROA 14.87% 12.68% 20.89% 21.89% 24.66% 26.22% 32.78% 38.53% 11.59% 6.87% ROE 19.85% 16.95% 26.60% 26.42% 29.77% 32.45% 41.68% 51.67% 16.10% 9.76% ROCE 26.48% 21.94% 33.00% 36.59% 41.71% 44.18% 56.95% 74.38% 22.42% 14.28% Fixed Asset Turnover 1.13 1.05 1.29 1.44 1.42 1.35 1.39 1.79 1.06 0.81 Receivable days 108.22 104.87 106.80 160.03 148.42 111.49 87.54 59.62 67.04 85.58 Inventory Days 87.15 89.27 78.34 63.55 61.40 55.63 53.17 49.83 113.67 133.37 Payable days 179.16 144.10 192.42 36.90 30.92 29.60 45.56 48.65 29.49 39.71 Cash Conversion Cycle 16.22 50.04 -7.28 186.68 178.90 137.51 95.15 60.81 151.22 179.23 Total Debt/Equity 0.02 0.05 0.09 0.02 0.02 0.05 0.04 0.03 0.11 0.14 Interest Cover 33.65 40.31 300.20 109.58 238.74 144.64 156.79 119.05 19.33 5.94

Description Mar 23 Mar 22 Mar 21
Book Value (Rs.) 123.30 105.45 95.52 ROA 15.00% 12.43% 20.89% ROE 20.06% 16.64% 26.60% ROCE 26.70% 21.66% 33.01% Fixed Asset Turnover 1.18 1.05 1.29 Receivable days 103.56 104.87 106.80 Inventory Days 83.40 89.27 78.34 Payable days 179.16 144.10 192.42 Cash Conversion Cycle 7.80 50.04 -7.28 Total Debt/Equity 0.02 0.05 0.09 Interest Cover 33.85 39.72 300.11

Top Investors:

nishtha jhunjhunwala discretionary trust

aryaman jhunjhunwala discretionary trust

aryavir jhunjhunwala discretionary trust

1575773 ontario inc

government pension fund global

ravindra raichand dharamshi

amal n parikh

max life insurance co ltd a/c participating fund

chanakya corporate services private limited

llp

Annual Reports:

News Update:

Concord Biotech gets GMP for unit II of Gujarat facility
23rd Feb 2024, 11:46 AM

The said inspection has been completed successfully, without any adverse remarks
Read More
Concord Biotech - Quarterly Results
8th Feb 2024, 18:15 PM

Read More

Concord Biotech Ltd.

Pharmaceuticals & Drugs

BSE: 543960 | NSE: CONCORDBIO

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Concord Biotech Ltd.

Pharmaceuticals & Drugs

BSE: 543960 | NSE: CONCORDBIO

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: